Ann: PAR Reports Successful Phase 2 Clinical Trial, page-35

BIT's increased 2400%, but who is counting

The problem is the biotech market seems to react to hype mostly so if the company hypes the result the SP goes up more. I have noticed the larger companies tend to have a bit more "smart money" that can see through the hype better than the nanocaps and that is reflected in the quality of discussion here on HC.

Today's result is quite positive (they at least reach their primary objective), but the water has been muddied a bit with the way they have presented the numbers. I wish companies would present all the raw data with these announcements so we can look into the results in detail to see if funny games are being played. If you have good results show the results.